key: cord-0540444-3bir3lyf
authors: Bar-On, Yinon M.; Sender, Ron; Flamholz, Avi I.; Phillips, Rob; Milo, Ron
title: A quantitative compendium of COVID-19 epidemiology
date: 2020-06-01
journal: nan
DOI: nan
sha: f4c3969015b0c637898164ec2a13ab3f7463f7f5
doc_id: 540444
cord_uid: 3bir3lyf

Accurate numbers are needed to understand and predict viral dynamics. Curation of high-quality literature values for the infectious period duration or household secondary attack rate, for example, is especially pressing currently because these numbers inform decisions about how and when to lockdown or reopen societies. We aim to provide a curated source for the key numbers that help us understand the virus driving our current global crisis. This compendium focuses solely on COVID-19 epidemiology. The numbers reported in summary format are substantiated by annotated references. For each property, we provide a concise definition, description of measurement and inference methods and associated caveats. We hope this compendium will make essential numbers more accessible and avoid common sources of confusion for the many newcomers to the field such as using the incubation period to denote and quantify the latent period or using the hospitalization duration for the infectiousness period duration. This document will be repeatedly updated and the community is invited to participate in improving it.

Structure of the document For each property covered in the current compendium, we present a set of curated studies from the literature best suited for estimating the specific property. For each study we provide an excerpt containing the estimate, to allow full transparency regarding the source of the estimate. Within each excerpt we use bold typeface to guide the readers' attention to the relevant estimate. In addition to presenting the curated set of studies, we also provide a best estimate for each property. Synthesizing estimates provided by all available studies into a singular quantity is challenging because different studies rely on different methodologies for measuring and estimating the property of interest, and thus each has its own associated biases and caveats. In our analysis, we do not attempt to rigorously assess the credibility of each study, but rather provide a best estimate which is the result of our judgement after reading the relevant background material.

Further details are provided in the following dedicated subsections. All graphs are schematics and not data. Some values represent population-level median and do not describe inter-individual variability, which is substantial. Insights from the data 47

Definition : Time between infection and the onset of infectiousness. Because this time varies from patient to patient, it is best characterized by a distribution, as shown in the figure.

Best estimate :

Methods of measurement and estimation : To calculate the latent period, we would ideally like to know the timing of infection and the time-dependent infectiousness profile for a large number of people. Individual profiles could then be combined to calculate an infectiousness profile (infectiousness as a function of time since infection) for COVID-19. The infectiousness profile is a continuous distribution, so the latent period can then be defined as the time interval that must pass before half-maximal infectiousness. The two main methods of estimating the duration of the latent and infectiousness periods durations are i) use of known infector-infectee pairs, and ii) fitting epidemiological compartmental models.

Estimates :

• Epidemiological models (for early stages in China): ○ (Li et al. 2020) -"In addition, the median estimates for the latent and infectious periods are approximately 3.69 and 3.48 days, respectively. " Table S1 " Latency period (Z, days) (95% CIs) (3.48, 3.90 ) " ○ (Tian et al. 2020) - Table 3 . The table reports an incubation period of 4.9 days ( 4.32 to 5.47 95% CI). However, the value presented in the table actually represents the latent period and is mistakenly called the incubation period.

• Infector-Infectee pairs ○ 77 pairs from China: (He et al. 2020) - Figure 1C reports the infectiousness profile as a function of days from symptom onset. We use the time it takes the infectiousness to reach half its peak, which happens two days before symptom onset. As symptoms arise after 5 days (see incubation period), this means the latent period is about 3 days. ○ 11 pairs from several countries (Ma et al. 2020 ) -" The mean and standard deviation were 7.44 days and 4.39 days for incubation period, 2.52 days and 3.95 days for the upper limit of latent period " Caveats (see further insights and analysis in a dedicated section ):

• Epidemiological models usually use the dynamics of the epidemic to infer a population-level characteristic (e.g. median or mean). The structure of the model inherently determines the distribution of the latent period. For example, in the standard SEIR model, the latent period is assumed to be exponentially distributed. • Simple SEIR-type models assume infectiousness onset occurs at a specific time, before which a person is not infectious and after which they become fully infectious. A more realistic scenario is that infectiousness increases gradually throughout the infection progression, and thus the definition of the latent period is harder to nail down. We use the time until half maximal infectiousness as the definition for the latent period in infector-infectee pair data. • When estimating the population median latent period from infector-infectee pairs, there is an inherent assumption that the infectiousness profile of different people is similar. Even though this assumption does not fully capture the variability between individuals for example based on their age or based on the state of their immune system, it is a conscious choice made to reduce the complexity of the models, and results in an effective value that averages across this variability.

• There is often confusion in the literature between the latent period and the incubation period, the latent period being the time before the onset of infectiousness and the incubation period being the time before onset of symptoms. Many manuscripts refer to the properties of the latent period but write it as the incubation period or use the value of the incubation period to describe the latent period.

Definition : Characteristic duration over which a person is infectious.

Best estimate :

Methods of measurement and estimation : The two main methods for estimating the duration of infectiousness is (i) use of data from infector-infectee pairs, and (ii) fitting epidemiological compartmental models. When using data reported by infector-infectee pairs, it is difficult to determine the exact time of infection. Instead, patient-reported timing of symptom onset is used to determine the lag between infector symptoms and infectee symptoms, also known as the serial interval (see " Serial interval/Generation interval " section). This data is combined with independent data on the distribution of incubation periods (the time from infection to symptom onset), to infer a distribution of generation intervals (time from infection of the infector to the infection of the infectee).

As it quantifies the probability of transmission per day post infection, the distribution of generation intervals is also commonly used to infer an "infectiousness profile" for infected patients. The difference between the generation interval distribution and the infectiousness profile is that the first represents a distribution of the probability of a secondary infection after a given time interval since the first infection, while the other represents a distribution of those transmission rates. Therefore, the integral of the generation interval distribution is by definition equal to one, while the integral of the infectiousness profile is the reproduction number R t . Thus, to convert the distribution of the generation intervals into an infectiousness profile, it is scaled by the average reproduction number (Ferretti et al. 2020) . As this is a continuous distribution, there isn't a single "infectious period" value, but one can define the interval between half the maximal infectiousness as a measure indicative of the infectious period duration. Alternatively, the infectious period can be inferred by fitting epidemiological compartmental models as these models relate the (unknown) infectious period to reported counts of cases and deaths.

Estimates :

• Infector-Infectee pairs ○ (77 pairs from China): (He et al. 2020) - Figure 1C reports the infectiousness profile as a function of days from symptom onset. We quantify the interval between the time points of half the maximal infectiousness based on the infectiousness profile, which is about 4 days. ○ (44 pairs from various countries):

(Ferreti et al. 2020) -" The distribution is best described by a Weibull distribution (AIC=148.4, versus 149.9 for gamma and 152.3 for lognormal distribution) with mean and median equal to 5.0 days and standard deviation of 1.9 days ". The infectiousness profile has the same distribution as the generation time distribution.

• Epidemiological compartmental models (for early stages of the epidemic in China):

○ (Li et al. 2020) -" In addition, the median estimates for the latent and infectious periods are approximately 3.69 and 3.48 days, respectively. " Table S1 " Infectious period for documented infections (Dr , days) Caveats (see further insights and analysis in a dedicated section ):

• Interventions will affect the duration of the infectious period. For example, isolation of infected individuals with symptoms limits their chances to infect non-household members. This reduces the overall number of infections, and shortens the time in which such infections occur, and hence the infectious period duration. • Epidemiological compartmental models usually use the dynamics of the epidemic to infer the population-level characteristic (e.g. median or mean). The structure of the model inherently determines the distribution shape for the infectious period. For example, in the simple Susceptible-Exposed-Infectious-Recovered (SEIR) model, the distribution of the infectious period is assumed to be exponential. • Simple SEIR-type models assume infectiousness is constant throughout the infectious period, and that the start and end of infectiousness occurs abruptly. A more realistic scenario is that infectiousness increases gradually throughout the progression of the infection and then decreases. In this scenario, the semantics of the infectious period is harder to define. We use the duration in which a person has infectiousness higher than half of the maximal infectiousness as the definition for inference of the infectiousness period from infector-infectee pairs data. • When estimating the population median infectious period from infector-infectee pairs, there is an inherent assumption that the infectiousness profile of different people is similar. Even though this assumption does not fully capture the variability between individuals for example based on their age or based on the state of their immune system, it is a conscious choice made to reduce the complexity of the models, and results in an effective value that averages across this variability. • One should be careful not to confuse the infectious period duration with the time from infection until someone can be infected. There is a latent period duration that adds to the infectious period and together these two distributions determine the time from being infected until infecting others. In addition, there is also wide variation among cases in their infectiousness profile, so the infectious period duration should be used as a statistical value rather than the maximal date after which people stop being contagious. • Another source of confusion is usage of the duration of illness or hospitalization as the duration of infectious period. The infectious period is much shorter than the overall duration of illness (which is often on the order of a few weeks). People's illness is usually prolonged due to the inflammatory response of the immune system. Thus people usually stop being strongly contagious well before they recover from the disease. The dynamics of the epidemic is governed by the infectious period and not by the time of overall illness duration.

Definition : Time from infection until onset of symptoms in symptomatic cases.

Best estimate :

Methods of measurement and estimation : There are two main methods for estimating the incubation period of COVID-19. The first is based on investigation of possible exposure times for reported cases. This usually entails collecting information on possible exposure time for a set of cases, and combining this information with records of the onset of symptoms. A statistical model is used to fit the data with a possible distribution of incubation times. The second method is based on epidemiological models. In this approach, exponential growth is used to model the dynamics of the epidemic, and a certain functional form is assumed for the distribution of the incubation period. The observed number of cases is a combined result of viral transmission (the output of the exponential growth model), and the distribution of incubation period (causing an infected person to show symptoms and thus be detected as a case). The model parameters, both for the exponential growth model, (similar to those described in the effective reproduction number section) as well as for the incubation period, are inferred such that the model's projections match case data as closely as possible.

Estimates :

• • There is often confusion in the literature between the latent period and the incubation period, the latent period is defined as the time before the onset of infectiousness and the incubation period is defined as the time before onset of symptoms. Many manuscripts refer to the properties of the latent period but incorrectly identify it as the incubation period or use the value of the incubation period to describe the latent period.

Generation interval ≡ Average time between infection events in an infector-infectee pair. Serial interval ≡ Average time between symptom onsets in an infector-infectee pair. See Figure 1 for a graphical representation.

The serial interval distribution is a combination of the generation interval distribution with the incubation period distribution. The expected values of the serial and generation interval distributions are expected to be equal but their variances are different. The variance of the serial interval equals the sum of variances of the generation interval and the incubation period, and thus is larger. The generation interval is more useful for describing viral spread than the serial interval, because it directly relates to the timing of infection. Unfortunately, this distribution is harder to estimate than the distribution of serial intervals because people do not typically know when they were infected.

Interventions such as isolation of symptomatic patients and contact tracing could shorten these two intervals by replacing lower frequency and shorter duration contact (e.g. at work and social gatherings) with high-frequency and long duration contact at home . The interventions lower the mean and median serial interval by censoring the distribution of serial intervals (among the various infected-infectee couples).

Best estimate : No interventions : 7 days Isolation of symptomatic patients and contact tracing: 4-5 days

Methods of measurement and estimation : Estimation of the serial interval is based on identification and tracking of chains of transmission.

Identifying the precise moment of infection is challenging, so most researchers use patient-reported timing of symptom onset, which is available in more cases. Data regarding symptom onset of identified pairs of infector-infectee is collected through detailed interviews. The delay between the onset of symptoms of each pair is sometimes used to calculate descriptive statistics (median, mean, standard deviation) and, in other cases, is used to fit an a priori distributional model. In order to estimate the generation interval from the serial interval, one must account for the incubation period because the infector is not infectious during this time. In some sources, symptom onset timing from infector-infectee pairs is combined with a reported distribution of incubation periods to estimate the generation time by fitting to a parametric distribution. I n most cases, the fit distributional parameters are allowed to assume a wide range of values, such that the assumptions have a minimal effect on the fit . Figure S7 ) and ) after the lockdown"

• Serial interval measured in countries that implemented isolation of symptomatic patients, physical distancing and contact tracing: ○ Korea -(Ki et al. 2020) -" The mean and median serial interval was estimated to be 6.6 days (range 3-15) and 4.0 days , respectively, based on data of both first-generation and second-generation patients" (The mean duration between symptom-onset and quarantine/isolation was 4.3 days) ○ Hong Kong ■ 21 transmission chains (S. Zhao, Gao, et al. 2020 • Measurement from multiple countries data aggregating effects of their different interventions:

○ China, Japan, Singapore, South Korea, Vietnam, Germany and Malaysia -689 transmission pairs (Ma et al. 2020) "The serial interval was estimated for 689 pairs of infector-infectee and ranged from −5 to 24 days (Table 2) , with a median of 6 days. It was smaller than 0 (mean: −2.63 days) for 27 (3.92%) pairs, meaning that the infectee showed symptoms earlier than the infector. Assuming a normal distribution ( Figure  2 (C)), the mean was 6.70 days (95% CI: 6.31, 7.10) and standard deviation 5.20 days (95% CI: 4.91, 5.46) ." ○ China, Vietnam, Japan, Malaysia, Hong Kong, Taiwan -77 transmission pairs (He et al. 2020) "serial interval was estimated to have a mean of 5.8 days (95% confidence interval (CI), 4.8-6.8 days) and a median of 5.2 days (95% CI, days) based on a fitted gamma distribution, with 7.6% negative serial intervals" ○ Vietnam, South Korea, Germany, Taiwan, Singapore, China -28 transmission pairs (Nishiura, Linton, and Akhmetzhanov 2020) -"lognormal distribution was selected as the best-fit model (WAIC = 224.0) , while no significant differences from other models were identified. The median serial interval was estimated at 4.0 days (95% credible interval [CrI] : 3.1, 4.9)" ○ China, Vietnam, South Korea, Germany, Italy, Singapore, Hong Kong, Taiwan -40 transmission pairs (Ferreti et al. 2020) -"we directly estimated the generation time distribution from 40 source-recipient pairs...The distribution is best described by a Weibull distribution with mean and median equal to 5.0 day s and standard deviation of 1.9 days" .

Caveats (see further insights and analysis in a dedicated section ):

• The serial interval is affected by policies of isolation and physical distancing. As such, measurements from one place and time (e.g. Wuhan before lockdown) should not be applied to another location (e.g. Lombardy after lockdown) without explicit explanation. As mentioned for example in (Bi et al. 2020) : " It should be noted this estimate includes the effect of isolation on truncating the serial interval. Stratified results show that if the infector was isolated less than 3 days after infection the average serial interval was 3.6 days, increasing to 8.1 days if the infector was isolated on the third day after symptom onset or later". • In general it is hard to track large networks of transmissions. Some sources use very small numbers of infector-infectee pairs (e.g. < 10) to arrive at an estimate. • Possible biases in the selection of the pairs used for the analysis. In addition, recent contacts are easier to remember than distant contacts leading to bias in the backward contact tracing, toward shorter serial intervals. • Clusters of infections could make it difficult to determine which of several individuals is the infectee.

Comparison to other pathogens : Best estimate : situation specific (depends on location and interventions)

Methods of measurement and estimation :

The exponential growth rate is usually estimated by an exponential fit to the curve of cumulative infections.

Estimate: 

Caveats (see further insights and analysis in a dedicated section ):

• If the fraction of cases that get detected changes over time, for example due to increased testing, it can bias estimates. Various alternative data sources such as the number of deaths can be used to compensate for varying ascertainment rates. • Studies make different assumptions about when exponential growth began (estimates range from the end of November to 31th of December 2019), which leads to wide variation in estimates of the growth rate and doubling time. • Our analysis (available here ) suggests that m ost of the wide variation in the exponential growth rate, doubling times and reproduction number across studies of the Wuhan outbreak stems from the choice of the start date. Large exponential growth rates (and short doubling times) are mainly the result of assumptions regarding late initial time of exponential growth. • It is most difficult to estimate the magnitude of the outbreak in its early phases. The number of reported cases is not necessarily reliable, as case count data can be confounded by low surveillance intensity causing a deflation in the true number of cases. • In some cases inference was performed using international flight data and infected persons reported outside of China. Because of the low numbers of people traveling abroad compared with the total population size in Wuhan, this approach leads to substantial uncertainties. Inferences based on a low number of observations are prone to measurement error when data are incomplete or model assumptions are not fully justified. Furthermore, it was shown (Niehus et al. 2020 ) that in most countries there was underdetection of infected travellers returning from Wuhan (by a factor of close to 3 on average, when compared to the surveillance in Singapore). • (Q Zhao et al. 2020) describes in detail how various elusive statistical biases can arise in models that infer the epidemic progression, usually resulting in underestimations. • The growth rate is connected to the reproduction number via the generation interval. Similar estimates for the growth rate may result in different reproduction numbers depending on different assumptions regarding the generation interval and its distribution. See for example (J. Wallinga and Lipsitch 2007) .

The basic reproduction number of an infection, R 0 , is the expected number of secondary infections generated by an average infectious case in an entirely susceptible population. This quantity determines the potential for an infectious agent to start an outbreak, the extent of transmission in the absence of control measures, and the ability of control measures to reduce spread. In contrast to R 0 , the effective reproduction number, R t (also denoted R(t) and R e ), measures the number of secondary cases generated by an infectious case once an epidemic is underway (see the designated section for further details).

Best estimate : 2-6 (corresponding to doubling time of 2.5-7 days)

Methods of measurement and estimation : R 0 and R t values are derived from fitting epidemiological models to data about the pandemic. These data can include the number of reported cases, hospitalizations and deaths. Importantly, since R 0 values are the product of a fitting procedure, their values depend on both the model and the quality of the underlying data. One approach to estimating R 0 is based on fitting the cumulative number of cases during initial phases of the epidemic. To estimate R 0 this approach usually relies on the most basic connection between R 0 and the doubling time and growth rate ( r ). These two parameters are interrelated via the generation interval (see relevant section). For a characteristic value of the generation interval g (units of days), with an exponential growth rate r (units of days -1 ) the connection is given by . The epidemic grows by a factor of R 0 over each generation interval. In general, R 0 = e rg the generation interval is characterized by a distribution g(t), where t is the time since infection, and not a single value, and the connection to R 0 is expressed through the Lotka-Euler equation:

. Here, M is the moment generating function of g(t), which has a familiar g(t)dt (− )

form for commonly used distributions. For a generation interval with a normal distribution where, are the mean and standard deviation of the generation interval (J. Wallinga R 0 = e rμ− (rσ) 2 1 2 , μ σ and Lipsitch 2007) . This is also a good approximation for generation intervals following a gamma distribution. Other approaches use a compartmental model to estimate R 0 .

Here R 0 is derived from the rates connecting the different compartments. For example, in an SIR (Susceptible-Infected-Removed) model,

where is the effective contact rate, and is the removal rate, equal to the inverse of R 0 = γ β β the period of infectiousness. For general compartment models (such as SEIR) R 0 is given by the highest eigenvalue of the generation matrix (also known as the spectral radius). Various sources estimate R 0 using the growth in the first stages of the outbreak and inference of the relevant rates from comparison to the number of infected. Comparison to various proxy data (exported cases, number of deaths) are used to validate and improve fits.

Estimates :

• Outbreak in Wuhan and mainland China: ○ Estimations on the basis of the number of cases exported from Wuhan to cities outside in mainland China and other countries: " Using the serial interval distribution above, we estimated that R 0 was 2.2 (95% CI, 1.4 to 3.9)" . (the shorter generation time is closer to estimates of SARS-Cov2) ■ (Tang et al. 2020) -modified SEIR (including isolation) -"Likelihood-based estimation of Rc during the outbreak in Wuhan gives a mean value of 6.39 with mean and variance of generation time of 6 and 2 days on the basis of a revised data series (dataRev1). The reproduction number based on likelihood-based estimation ranges from 1.66 to 10 " (They assume exponential growth started at 1 Jan, resulting in a very high growth rate. Doubling time was about 2 days. High number of parameters in their model) ■ (S. Zhao, Lin, et al. 2020 ) -exponential growth "In Table 1 , we estimated that the R 0 ranges from 2.24 (95%CI: 1.96-2.55) to 5. ) associated with an 8-fold to 0-fold increase in the reporting rate" ■ (S. Zhao, Musa, et al. 2020 ) -exponential growth with correction for underreporting of cases -"After accounting for the effect of under-reporting, the R 0 was estimated at 2.56 (95% CI: 2.49-2.63), see Figure 1b , which is consistent with many existing online preprints with range from 2 to 4 [5,20-22] ." • Beginning of Spreading in other countries:

○ South Korea and Italy -(Zhuang et al. 2020) -" We modelled the transmission process in the Republic of Korea and Italy with a stochastic model, and estimated the basic reproduction number R 0 as 2.6 (95% CI: 2.3-2.9) or 3.2 (95% CI: 2.9-3.5) in the Republic of Korea, under the assumption that the exponential growth starting on 31 January or 5 February 2020, and 2.6 (95% CI: 2.3-2.9) or 3.3 (95% CI: 3.0-3.6) in Italy, under the assumption that the exponential growth starting on 5 February or 10 February 2020, respectively" -assumed short serial interval distribution -gamma with mean 4.5 and standard deviation of 3.1 days -might be good estimate for Korea due to their aggressive policy, but not necessarily for the beginning of the epidemic in Italy. ○ Iran -(Muniz-Rodriguez et al. 2020b) -"To determine the transmission potential of severe acute respiratory syndrome coronavirus 2 in Iran in 2020, we estimated the reproduction number as 4.4 (95% CI 3.9-4.9) by using a generalized growth model and 3.5 (95% CI 1.3-8.1) by using epidemic doubling time." -assumed short serial interval distribution: gamma with mean 4.5 and standard deviation of 3.1 days, despite no aggressive interventions.

Comparison to other pathogens :

• 

• It is most difficult to estimate the magnitude of the outbreak in its early phases. The number of reported cases is not necessarily a good source, as case count data can be confounded by low surveillance intensity causing a deflation in the true number of cases. Another source for inconsistency is incidents originated by contact with Wuhan seafood market rather than contact with other infected individuals.

• In some cases inference was performed by using international flight data and infected persons reported outside of China. Because of the low numbers of persons traveling abroad compared with the total population size in Wuhan, this approach leads to substantial uncertainties. Inferences based on a low number of observations are prone to measurement error when data are incomplete or model assumptions are not fully justified. Furthermore, it was shown (Niehus et al. 2020 ) that in most countries there was underdetection of infected travellers returning from Wuhan (by factor of close to 3 in average, when compared to the surveillance in Singapore).

• (Q Zhao et al. 2020) describes in detail how various elusive statistical biases can arise in models that infer the epidemic progression, usually resulting in underestimations. • The reproduction number is connected to the serial interval and growth rate. The early sources didn't have reliable estimates for those, and thus are affected by the quality of their assumptions. • Our analysis suggests that m ost of the wide variation in the exponential growth rate and reproduction number across studies of the Wuhan outbreak stems from the choice of the start day. Large reproduction numbers are mainly due to assumptions regarding late initial time of exponential growth.

The effective reproduction number, R t (also denoted by R(t), R and R e ) is the number of secondary cases generated by an infectious case at a given moment (t) once an epidemic is underway. Unlike the basic reproductive number, R t is time and situation specific, used to characterize pathogen transmissibility during an epidemic, and enabling assessment of the effectiveness of interventions.

We should also emphasize the distinction between the 'physical' versus 'operational' meaning of R t : the 'physical' meaning of the number of infections an infectious person makes on average (as defined above) does not depend on the generation interval. However, the operational definition which is inferred from models fitted to the number of cases or derived from logarithmic slope of infection curves depends on serial interval.

Best estimate : situation specific (depends on location and interventions)

Methods of measurement and estimation : Like the basic reproduction number, R t values may be derived from fitting epidemiological compartmental models to data about the pandemic. These data can include the number of reported cases, hospitalizations and deaths. The two basic types of models are compartment-based models, such as SIR and SEIR, and renewal-equation models (see details below). Estimation of effective R t via compartment models is similar to the estimation of R 0 , and it makes use of the assumptions built into the model, such as: the different compartments and the distribution of time in each compartment. In order to estimate the effects of different interventions, such epidemiological models are also used to predict the R t based on assumptions and observed epidemiological parameters. Other approaches for estimation of the effective reproduction number use only the serial/generation interval via the renewal function, like those of (Cori et al. 2013; Jacco Wallinga and Teunis 2004) . Renewal-equation estimates themselves can be divided into two basic methods, which differ by the inference method, as well as the use of right censored data:

• The first method (Jacco Wallinga and Teunis 2004) makes use of both past and future daily cases respective to the time step at which R t is inferred. Thus, it estimates the average number of secondary cases that a case infected at time step t eventually infected, estimated in retrospect. This method is also referred to as the "case reproduction number". • The second method (Cori et al. 2013; Thompson et al. 2019 ) only uses past daily cases. Hence, the method estimates the average number of secondary cases that each infected individual would infect if the conditions remained as they were at time t. This method is also referred to as "the instantaneous reproduction number".

Estimates :

• Intensive interventions : isolation of patients with symptoms, contact tracing, physical distancing, including restriction (or advising against) of large social gatherings in order to mitigate the risk of community transmission: ○ Singapore (Tariq et al. 2020) -characterized daily incidence of local cases using the generalized logistic growth model (GLM) after adjusting for imported cases: " The effective reproduction number peaked with a mean value 1.0 between February 6-12, 2020 and declined thereafter. As of March 5, 2020, our most recent estimate of R t is at 0.9 (95% CI: 0.7,1.0) " ○ South Korea (Shim et al. 2020) -generalized growth model: " ... the intrinsic growth rate (r) was estimated at 0.6 (95% CI: 0.6, 0.7) and the scaling of growth parameter (p) was estimated at 0.8 (95% CI: 0.7, 0.8), indicating sub-exponential growth dynamics of COVID-19 in Korea (Figure 2 , Table 3 ). The mean reproduction number R t was estimated at 1.5 (95% CI: 1.4, 1.6) as of Feb 26 2020 ." ○ Hong Kong (Cowling et al. 2020) -Using the method by (Thompson et al. 2019) , improved version of the approach of (Cori et al. 2013 ) " Although unlinked COVID-19 cases have been detected in increasing numbers since early March, transmissibility (R t ) remains around the critical threshold of 1 (figure 2)" ○ Sweden -no lock down (Folkhalsomyndigheten 2020) -using (Jacco Wallinga and Teunis 2004) method -"During the first month the estimates of Re were very unstable. After that, R e reached a maximum of 1.4 at the beginning of April, and steadily decreased after that. By the middle of April R e fluctuated around the value of one during a week, and since 21 April it has slightly dropped below one " (based on the incidence growth curve, assuming serial interval of 4.8 days)

• Interventions in Wuhan -before and after lockdown ○ (Lipsitch M, Keya J, Cobey S.E. 2020) following (Pan et al. 2020) -using (Jacco Wallinga and Teunis 2004) method during the period of local lockdown (period 3) R t dropped below 1 and reached 0.3 by the end of March -"taking into account the evident decline of the epidemic curve that began during Period 3, finds that R t dropped below 1 during Period 3, specifically on 28-29 Jan. (Fig. 1) " ○ (C. Wang et al. 2020) -extended SEIR model to account for population movement, unascertained cases, and quarantine by hospitalization -"The effective reproductive number dropped from 3.86 (95% credible interval 3.74 to 3.97) before interventions to 0.32 (0.28 to 0.37) post interventions" • Interventions in other countries -before and after lockdown ○ France (Salje et al. 2020 ) -deterministic compartmental model stratified by age -from figure 4, R 0 =3.3 and R lockdown =0.5 ○ 11 European countries (Flaxman et al., 2020) -semi-mechanistic Bayesian hierarchical model attempts to infer the impact of the various interventions (assuming each has the same relative effect on R, independent of the country). Based on reported death cases -"We estimate large changes in in response to the combined non-pharmaceutical interventions. Our results, which are driven largely by countries with advanced epidemics and larger numbers of deaths (e.g. Italy, Spain), suggest that these interventions have together had a substantial impact on transmission, as measured by changes in the estimated reproduction number R t . Across all countries we find current estimates of R t to range from a posterior mean of 0.97 [0.14-2.14] for Norway to a posterior mean of 2.64 [1.40-4.18] for Sweden, with an average of 1.43 across the 11 country posterior means, a 64% reduction compared to the pre-intervention values"

Caveats (see further insights and analysis in a dedicated section: How does the basic reproduction number, R0, relate to the doubling time of the epidemic? ):

• Various interventions such as isolation of symptomatic patients and contact tracing affect both the average number of secondary cases generated by an infected individual as well the serial interval itself.Usually the models assume a constant serial interval and consider only possible changes in R t . Thus the models infer the 'operational' R t that correspond to a constant serial interval.

• Similar to the basic reproduction number, the effective reproduction number also depends on the quality of the data regarding the number of cases taken as is from formal reports, or estimated based on proxies such as traveling data. • Other caveats relevant to the basic reproduction number are also relevant to the time specific statistics:

○ It is most difficult to estimate the magnitude of the outbreak in its early phases. The number of reported cases is not necessarily a good source, as case count data can be confounded by reservoir spillover events, stochasticity in the initial phase of the outbreak, and low surveillance intensity. ○ inference was performed by using international flight data and infected persons reported outside of China. Because of the low numbers of persons traveling abroad compared with the total population size in Wuhan, this approach leads to substantial uncertainties . Inferences based on a low number of observations are prone to measurement error when data are incomplete or model assumptions are not fully justified. Furthermore, it was shown (Niehus et al. 2020 ) that in most countries there was underdetection of infected travellers returning from Wuhan.

Comparison to other pathogens :

• SARS -○ ( 

The "offspring distribution" of an epidemic is the distribution of the number of secondary cases due to each primary infection. The mean of this distribution is R t by definition, though R t values derived from fits might differ from this true R t value due to incorrect assumptions or issues associated with the fitting process. The offspring distribution is generally considered to adopt a negative binomial distribution which is characterized by a mean (R t ) and a dispersion parameter k, such that the variance is given by R t (1+R t /k). The negative binomial distribution is generally used instead of Poisson to allow for unequal mean and variance. Smaller values of k indicate greater heterogeneity. In general k<<1 is associated with a high number of 'superspreaders' -individuals that infect much more than the average R 0. Values of k>1 are associated with a low number of 'superspreaders', as the number of secondary cases of each primary infection is relatively even.

The formula for the probability density p of the number of secondary infections n, is given by:

where R t is the mean number of secondary cases, k is the dispersion of the Methods of measurement and estimation : Estimation is made based on a chain transmission model, in which each infected person transmits the infection to a number of subjects sampled randomly from a distribution with mean R t and dispersion k. Usually, the model is compared to data regarding the size of different clusters (for different countries, for example) with an initial number of spreaders (for example, known imported cases).

Other methods use empirical data regarding the number of secondary cases in a defined cluster with good documentation. They fit the transmission data to a negative binomial distribution to extract an estimate for the dispersion parameter. A version of this method, proposed by (Lloyd-Smith et al. 2005 ) makes use of only the average number of secondary cases and the proportion of cases with no secondary transmission by numerically solving an equation that connects the probability of no-transmission with the dispersion.

Estimates :

• Caveats :

• Some of the analysis relies on the overall size of clusters and their initial number of spreaders. However, in an emerging disease it is hard to assess the total size of the cluster as it depends on the fraction of the population being tested (and the testing policy). In addition, the initial number of (imported) cases may be influenced by misdetection of a few cases. • It is not always clear from case reports which cases are epidemiologically linked. Hence, the extent and precision of the epidemiological investigation could also affect the assessment of cluster sizes and the proportion of cases with no secondary infections. • Many of the interventions meant to control the spreading, like isolation of symptomatic patients and contact tracing, affect the dispersion, as they aim to prevent events of large spreading (as well as the mean = R 0 ). Thus, it is important to divide the data according to the level of intervention 

Definition : The fraction of infected people not showing noticeable symptoms throughout their infection. Note, this is different from pre-symptomatic patients, who carry the virus but will only show symptoms later (once their incubation period has passed).

Best estimate : 20-50% overall, with strong age dependence such that estimates depend strongly on demographics.

Methods of measurement and estimation : There are two main methods for estimating the fraction of asymptomatic infections. The first method randomly samples the population to identify the subset of infected individuals, and then follows-up on those cases to see if they develop symptoms.

The second method relies on epidemiological compartment models. In these models, the fraction of asymptomatic cases can be represented by a unique compartment separate from the symptomatic cases. The fraction of asymptomatic cases is one parameter in this model, which could be fitted, i.e. inferred, along with the other parameters of the model, to time course data of the epidemic.

Estimates :

• case-patients in spreading the disease is of great concern. Among 97 confirmed COVID-19 case-patients in this study, 4 (4.1%) remained asymptomatic during the 14-days of monitoring " (72%) were women; mean age was 38 years (range 20-80 years) ○ Shenzhen, China -391 cases - (Bi et al. 2020) " Further, in (Fig 2b) , with 20% of infections in children under 10 resulting in clinical cases, rising to over 70% in adults over 70 in the consensus age distribution estimated across all regions." Thus, 80% asymptomatic cases in children under 10 and 30% in adults over 70. A simple average over the averages of the age groups in Table 3 yields an average of 57% . Non clinical cases include asymptomatic as well as mild cases, not reported or documented.

Caveats :

• Reporting of mild symptoms is subjective and so the dividing line between pre-symptomatic and asymptomatic cases is not well-defined. • While in some cases, a large collection of samples were taken, it is very challenging to take a truly random sample of a large population. Many studies report the asymptomatic fraction for a highly idiosyncratic study population that certainly differs greatly from the general population, for example the passengers of the Diamond Princess cruise ship.. • To estimate the true fraction of asymptomatic cases, researchers need to follow-up on cases which did not show symptoms at the time of testing to verify that these are truly asymptomatic and not presymptomatic cases. • Even though there is evidence that asymptomatic cases have viral loads similar to those of symptomatic cases , there are, on the other hand, also reports of a connection between the severity of symptoms and viral load . Thus there are contradictory reports on the relationship between symptom severity and the viral load, so it is unclear if asymptomatic cases would be harder to detect in random surveys. If asymptomatic cases indeed go undetected, this will cause an underestimation of their true fraction. • When performing random population testing, the false positive and false negative rates of the test need to be accounted for in order to accurately project the associated uncertainty of the estimates based on the tests. This may lead to significant over-estimation of asymptomatic cases in screening tests, where the disease prevalence is very low. • A recent review (Oran and Topol 2020) states in its abstract, based on data largely overlapping with the sources provided above, that a range of 40%-45% of infections are asymptomatic. Such a narrow confidence range is hard to support given the large variation in the fraction of asymptomatic infections between studies, as well as other possible biases and caveats described above. In the discussion it is stated less conclusively:

"On the basis of the 3 cohorts with representative samples-Iceland and Indiana, with data gathered through random selection of participants, and Vo', with data for nearly all residents-the asymptomatic infection rate may be as high as 40% to 45%. A conservative estimate would be 30% or higher to account for the presymptomatic admixture that has thus far not been adequately quantified"

Lower quality data Caveats (see further insights and analysis in a dedicated section ):

• The detection of cases following a contact tracing study may miss some of the infections if the timing of the study is in sync with the progression of infection of household members, and is subject to the detection error rates of the detection method. • In some cases only clinical cases are identified, thus underestimating the true secondary attack rate. • There could be cases in which there was either more than one infector in the household, or that some people in the household got infected from a source other than the household. • The specific attack rate could change based on the awareness of the disease, hygiene and physical distancing measures.

Definition : The total number of fatalities divided by the total number of confirmed cases Best estimate : 1-15% (uncorrected for age structure, selection bias, ascertainment rate, time delays etc.)

Methods of measurement and estimation : Descriptive statistics based on summary of gathered data. Possible biases not taken into account in this estimate are specified in the caveats section.

Estimates :

• Global country statistics from Worldometer analyses by our open script (accessed on 31/05/2020) -We use data from all countries with more than 50 death cases and calculate the uncorrected raw Case Fatality Rate for each country. The range represents the lowest and highest rates observed.

• Several key factors can affect the death toll. First, demographic parameters and practices associated with increased or decreased risk differ greatly across societies. For example, the capacity of the healthcare system, the average age of the population, and the prevalence of smoking. Indeed, the majority of people dying from SARS-CoV-2 have a preexisting condition such as a cardiovascular disease or smoking (China CDC 2020) . • There is a potential for overestimating the CFR due to a tendency to identify more severe cases (selection bias) which will tend to overestimate the CFR. • There is usually a delay between the onset of symptoms and death, which can lead to an underestimate of the total number of deaths early in the progression of an epidemic. • Attribution of cases could sometimes be challenging, with some deaths unaccounted for due to lack of testing or due to registration under a different cause of death.

Estimates of corrected CFR:

• Wu et al. 2020 -" Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9-2.1%) "

Definition : The total number of fatalities divided by the total number of infected people Best estimate :

Methods of measurement and estimation : Estimating the total number of infected people, and thus the IFR, requires testing a random sample of the population.

The main methods used for estimating the IFR are:

• Testing of semi-random samples using RT-qPCR • Testing of semi-random samples via serology (antibody) testing • Model-based estimates Because people who were infected and recovered do not show as positive with viral RNA quantification methods, the ideal way to estimate the number of infected people is testing for the presence of antibodies (serosurvey) against SARS-CoV-2 in random samples. As serosurveys were not available in the early stages of the pandemic, researchers resorted to semi-random samples tested with qPCR, or to modelling-based estimates. As of writing (May 2020), several serosurveys are being conducted and results with IFR estimates are starting to be released. Caveats : Caveats associated with estimating the IFR can be divided into those affecting the numerator, i.e. the total number of fatalities, and those affecting the denominator, i.e. the total number of infected people.

• Caveats associated with estimating the number of fatalities: ○ Demographic parameters and practices associated with increased or decreased risk differ greatly across societies. For example, the capacity of the healthcare system, the average age of the population, and the prevalence of smoking. Indeed, the majority of people dying from SARS-CoV-2 have a preexisting condition such as cardiovascular disease or smoking (China CDC 2020) . ○ There is usually a delay between the onset of symptoms and death, which can lead to an underestimate of the total number of deaths early in the progression of an epidemic. ○ Attribution of cases could sometimes be challenging, with some deaths unaccounted for due to lack of testing or due to registration under a different cause of death. • Caveats associated with estimating the total number of infected people: ○ To get a good estimate of the prevalence infected people using a random and representative sample of the population must be taken. In many cases, achieving such random sampling is very challenging, and in most cases it is hard to determine how representative the sample is. For example, people who have experienced the hallmark symptoms of SARS-CoV-2 may be more inclined to enroll in an open study. ○ When the prevalence of a disease is low, false positive results may skew the results significantly. Many of the tests done rely on methods with non-negligible false positive and false negative rates, and thus the reported estimates may have significant uncertainty associated with them, if the false positive rate of the test was not accounted for appropriately. ○ The detection of infected individuals using PCR based tests is sensitive to the time at which the test was performed relative to the progression of the disease in infected individuals. In the first days of infection or close to recovery, the viral load of infected individuals can be under the detection limit of PCR tests and thus infections might be missed. • Caveats specific to serosurveys:

○ The usage of a small number of defined SARS-CoV-2 proteins in antibody tests, e.g. spike and/or nucleoprotein, can result in underestimates. ○ The detection of infected individuals is sensitive to the time at which the test was performed relative to the progression of the disease. It requires about 2 weeks on average for antibodies to reach detectable levels.

Definition : The fraction of infected individuals that need to be hospitalized due to their conditions.

Best estimate : 2-4% of infected (hospitalization rate out of confirmed cases could be much higher, e.g. 20%, as most mild cases can remain untested)

Methods of measurement and estimation : Descriptive statistics based on summary of gathered hospitalization data. Often divided by age groups, gender and comorbidities. This value must be scaled to the total number of infected people, similar to the rescaling of CFR to infer IFR. Estimation of the number of infected people requires testing a random sample of the population. Because people who were infected and recovered do not show as positive with viral RNA quantification methods, the ideal way to estimate the number of infected people is testing for the presence of antibodies (serosurvey) against SARS-CoV-2 in random samples. As these were not available in the early stages of the pandmeic, researchers resorted to semi-random samples tested with qPCR, or to modelling-based estimates. Current estimates rely on semi-random samples, used to correct hospitalization data. (Figure 2 ) ". see figure for age distribution Caveats : Caveats associated with estimating the probability of hospitalization can be divided into those affecting the numerator i.e. the total number of individuals need to be hospitalized and those affecting the denominator, i.e. the total number of infected people.

• Caveats associated with estimating the number of fatalities: ○ Patients in need of hospitalization can be in different conditions. Health systems in places which suffer from a high number of infections would tend to hospitalize only patients with severe conditions, but in other situations patients with milder conditions would also be hospitalized. ○ Hostpitalization probability is highly dependent on age and sex, thus the overall hospitalization in a country is affected by its population age structure, as well as the different fraction of infected individuals (also known as "attack rate") among different ages. ○ Underlying conditions and comorbidity are factors affecting the severity of the disease.

Their prevalence is correlated with age, but differs between countries. Thus, it may alter the probabilities, and make it difficult to estimate it correctly for other countries.

• Caveats associated with estimating the total number of infected people in studies regarding early stages of the epidemic: ○ Non random sampling, common at early stages of the epidemic. ○ Reliance on a small number of individuals to assess the fraction of infected individuals is problematic, especially when it is further divided into several age groups. Specifically, the sample size of known cohorts for young ages (<20y) is very small.

Comparison to other pathogens :

• SARS - (Rainer et al. 2004 ) -very few percent do not need hospitalization " Of 910 patients who were managed without hospitalization, 6 patients had serologic evidence of SARS. Five of the 6 patients had normal chest radiographs, and 4 patients had symptoms such as myalgia, chills, coughing, and feeling feverish".

Definition : The fraction of hospitalized individuals that are admitted to the Intensive Care Unit (ICU). The probability of ICU admission is also often regarded as the fraction of hospitalized patients in critical condition (i.e., respiratory failure, septic shock, and/or multiple organ dysfunction or failure).

Best estimate : 10-40% (large variation between health systems).

Descriptive statistics based on summary of gathered hospitalization data. Often divided by age groups, gender and comorbidities.

Estimates :

• China, Wuhan ○ (D. Wang et al. 2020) -26% of hospitalized were admitted to ICU "Compared with patients who did not receive ICU care (n=102), patients who required ICU care (n=36) were significantly older (median age, 66 years [IQR, " Most cases were classified as mild (81%; ie, non pneumonia and mild pneumonia). However, 14% were severe (ie, dyspnea, respiratory frequency 30/min, blood oxygen saturation 93%, partial pressure of arterial oxygen to fraction of inspired oxygen ratio <300, and/or lung infiltrates >50% within 24 to 48 hours), and 5% were critical (ie, respiratory failure, septic shock, and/or multiple organ dysfunction or failure) " The estimate of 25% is based on dividing the number of critical cases by the number of severe cases (similar to critical out of hospitalized, as mostly only severe cases are hospitalized in a crowded health system) • Lombardy Region, Italy -(Grasselli, Pesenti, and Cecconi 2020) -" The proportion of ICU admissions represents 12% of the total positive cases, and 16% of all hospitalized patients. This rate is higher than what was reported from China, where only 5% of patients who tested positive for COVID-19 required ICU admission ".

• France, analysis of probability by age, based on data combined with incidents from Diamond Princess cruise ship - (Salje et al. 2020 ) -" Once hospitalized, 18.2% (95% CrI: 18.0%-18.6%) patients enter ICU after a mean delay of 1.5 days ( Figure S1 ). There is an increasing probability of entering ICU with age -however, this drops for those >70y ( Figure 2B , Table S2 ). ." (see table for distribution for sex and age). 7.3%, 4.2%, 4.1%, and 3.0% for the age groups ,1, 1 to 5, 6 to 10, 11 to 15, and >16 years, respectively...with much fewer being severe and critical cases (5.8%) than in adult patients (18.5%)"

Based on Table 2 , we estimate a probability of 10% for ICU admissions from the ratio of critical cases to cases in severe or critical condition ○ USA -(CDC COVID-19 Response Team 2020) about 10% -"Information on hospitalization status was available for 745 (29%) cases in children aged <18 years and 35,061 (31%) cases in adults aged 18-64 years. Among children with were reported to be hospitalized, with 15 (0.58%-2.0%) admitted to an ICU (Figure 2) " . (see figure for age distribution) Caveats :

• Patients in need of hospitalization can be in different physical conditions. Health systems in places which suffer from a high number of infections would tend to hospitalize only patients with severe conditions and thus have higher probability of ICU admission. • Both hostpitalization and ICU admission probabilities are highly dependent on age and sex, thus the overall hospitalization of a country is affected by its population age structure, as well as the different attack rate among different ages. • Underlying conditions and comorbidity are factors affecting the severity of the disease. Their prevalence is correlated with age, but differs between countries. Thus, it may alter the probabilities, and make it difficult to estimate it correctly for other countries. The risks of ICU admission and mechanical ventilation ranged from 44% to 100% and from 25% to 100%, with pooled estimates at 78% and 73%, respectively"

Definition : The fraction of infected patients that were admitted to the Intensive Care Unit (ICU) who didn't survive.

Best estimate : 20%-80%

Methods of measurement and estimation : Descriptive statistics based on summary of gathered hospitalization data. Often divided by age groups, gender, ethnicity and comorbidities.

Estimates :

• In health systems crowded by the outbreak: Table 5 , 78% (291/373) of the ICU patients who had outcomes (been discharged or died) have died. Due to the overcrowding of the health system, a similar number of patients have died without being admitted to the ICU -"Among the 2634 patients who were discharged or had died at the study end point, during hospitalization, 373 (14.2%) were treated in the ICU, 320 (12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidney replacement therapy, and 553 ( 21% ) died (Table 5) ." ○ Lombardy Region, Italy -(Grasselli et al. 2020) -61% of ICU patients with outcomes have died (405/661). 26% of admitted (including those stille in ICU). This fraction may be overestimated due to censoring effects.

"Among the 1581 patients with ICU disposition data available as of March 25, 2020, 920 • Patients in need of hospitalization can be in different conditions. Health systems in places which suffer from a high number of infections would tend to hospitalize only patients with severe conditions and thus have higher probability of ICU admission. Moreover, overcrowding of ICU may result in critical patients not being admitted to ICU at all. • Censoring of ICU outcomes (i.e. outcomes being available for only part of the patients during the spread) may bias the death probability to higher values as the duration of stay in ICU is longer for patients who recover. This is also shown in previous reports from ICNARC ( ICNARC 2020a , ICNARC 2020b ). • Hostpitalization, ICU admission and death probabilities are highly dependent on age and sex, thus the overall hospitalization in a country is affected by its population age structure, as well as the different attack rate among different ages groups. • Underlying conditions and comorbidity are factors affecting the severity of the disease. Their prevalence is correlated with age, but differs across countries.

Comparison to other pathogens :

• SARS -(Joynt and Yap 2004) -" Long-term mortality for patients admitted to the ICU ranges from 30% to 50% ." . cases, the death probability ranged from 58% to 75% .

Definition : The fraction of uninfected people who test positive for SARS-CoV-2 via RT-qPCR. The false positive rate is often reported as "specificity" which is the fraction of negatives test results that are true negatives (i.e. uninfected). The false positive rate (in %) is 100% -specificity. Caveats:

• RT-qPCR is used to quantify the amount of viral genomic RNA in patient samples. It works by monitoring the progress of a reverse-transcriptase (RT) PCR via the fluorescence of a DNA binding dye (or an oligonucleotide probe). Since DNA accumulates over the course of the reaction and dye fluorescence is increased by DNA binding, fluorescence reports on reaction progress. It is common to report "cycle threshold" or "quantification cycle" values (C t or C q values) for RT-qPCR. C q values report the cycle number at which dye fluorescence crossed a predefined threshold. The earlier the threshold is crossed, the lower the C q value and the more RNA was in the sample. A positive test is one with a C q value beneath a prespecified threshold (e.g. Ct < 40), though this threshold will vary from between specific tests (e.g. which primers were used). • The false positive rate or specificity of RT-qPCR testing is only rarely reported in studies investigating RT-qPCR tests of SARS-CoV-2. • False positives are likely to be dominated by errors in sample handling, as false positives are uncommon in RT-qPCR in general.

Definition : The fraction of people infected with SARS-CoV-2 who test negative by a single RT-qPCR test. The false negative rate is often reported as "sensitivity" which is the fraction of negative test results that are true positives (i.e. were previously infected). The false negative rate (in %) is therefore 100% -sensitivity.

Best estimate : 5-30 % depending on choice of kit and primers

Methods of measurement and estimation : RT-PCR testing of confirmed SARS-CoV-2 patients in the days immediately following the onset of symptoms. Patients are typically identified via an initial positive RT-qPCR test and a second diagnostic method, e.g. a CT scan of the lungs.

Estimates :

• RT-qPCR testing of confirmed SARS-CoV-2 patients ○ (J. Zhao Jr. et al. 2020) Figure 2 , Table 2 and results -"As the results shown in Figure 2 and Figure 3 gives a pooled sensitivity of 92% (95% confidence interval of 85-96%) for influenza A and 95% (87-99%) for influenza B.

Caveats:

• RT-qPCR is used to quantify the amount of viral genomic RNA in patient samples. It works by monitoring the progress of a reverse-transcriptase (RT) PCR via the fluorescence of a DNA binding dye (or an oligonucleotide probe). Since DNA accumulates over the course of the reaction and dye fluorescence is increased by DNA binding, fluorescence reports on reaction progress. It is common to report "cycle threshold" or "quantification cycle" values (C t or C q values) for RT-qPCR. C q values report the cycle number at which dye fluorescence crossed a predefined threshold. The earlier the threshold is crossed, the lower the C q value and the more RNA was in the sample. A positive test is one with a C q value beneath a prespecified threshold (e.g. Ct < 40), though this threshold will vary from between specific tests (e.g. which primers were used).

• The false negative rate of RT-qPCR testing appears to depend greatly on sample handling, storage and protocol details, for example the choice of primers and kits (Barra et al. 2020; Vogels et al. 2020) , which might explain the wide range of estimates. • Double testing of the same patient may substantially reduce the false negative rate and is recommended by the CDC and several references (Jiang et al. 2020) . However, the quantitative effect of multiple samples of the same individuals usually lowers the false negative rate to a lesser degree than expected when tests are statistically independent. For example, (Jiang et al. 2020 ) report a 22% false negative rate for a single test and 14% false negative rate for a double test. If we assume statistical independence, then the false negative rate for two tests should be 0.22 2 ≈ 5%. The empirical value of 14% represents an 8% reduction in the false negative rate, which is about ½ of the 17% reduction expected when tests are statistically independent. This lower-than-expected reduction could stem from the repeat tests not being completely independent, due, for example, to the timing of tests relative to the start of infection or the time the tests are taken during the time course of the infection of the infected individual.

• Similarly, confirmatory testing by CT scan (Jiang et al. 2020) or antibody tests (J. Zhao Jr. et al. 2020) reduce the false negative rate as well.

Definition : The number of days post symptom onset for which >50% of infected people test positive by RT-qPCR. Notably, viral shedding and, hence, PCR-positivity, begins several days after infection.

Best estimate : ≈7-9 days Methods of measurement and estimation : RT-PCR testing of confirmed SARS-CoV-2 patients in the days following the onset of symptoms. Patients are typically identified via an initial positive RT-qPCR test and potentially a second diagnostic method, e.g. a CT scan of the lungs.

Estimates :

• RT-qPCR testing of confirmed SARS-CoV-2 patients ○ (J. Zhao Jr. et al. 2020) Figure 2 , Table 2 and results -" As the results shown in Figure Figure 3 , which replots data from (Bi et al. 2020) Caveats:

• The period of >50% PCR positivity may not begin immediately after onset of symptoms. For example, one reference report a ≈1 day lag from symptom onset to 50% PCR positivity (J. Zhao Jr. et al. 2020 ) , but this reference had access to only one patient whose reported symptoms began on the same day as testing.

• Error rates associated with RT-qPCR testing will depend greatly on sample handling, storage and protocol details, which might explain the wide range of estimates. • As with all PCR testing, error rates and limits of detection will depend on the choice of primers and kits (Barra et al. 2020; Vogels et al. 2020) .

Definition : The fraction of uninfected people who test positive for SARS-CoV-2 antibodies. The false positive rate is often reported as "specificity" which is the fraction of negatives test results that are true negatives (i.e. uninfected). The false positive rate (in %) is 100% -specificity.

Best estimate : 0.1-15%, corresponding with a specificity of ≈85-99.8%

Methods of measurement and estimation : testing of samples from patients known not to have SARS-CoV-2 because the samples were taken before the epidemic began (e.g. banked blood donations).

Estimates :

• Zhao Jr. et al. 2020; ) these tests are not useful for diagnosing patients with active disease. Rather, serology testing or "serosurveys" are used to measure the incidence of the infection in the population at large in order to determine the state of the epidemic. Because these tests have non-trivial false-positive and false-negative rates, great care should be taken in interpreting the results of serosurveys.

• Since antibodies take ≈10 days to develop. However, the timing of infection is often unknown.

In practice, therefore, the timing of the test will be a major factor affecting test results. • Error rates will depend both on which testing approach (or specific kit) is used as well as the sample collection, storage and sample handling procedures. We report a range that includes kit-to-kit variability as reported in (Whitman et al. 2020 ) but this does not include between-lab differences in sampling, transport and preparation.

Definition : The fraction of previously infected people who test negative for SARS-CoV-2 antibodies. Since it takes time for antibodies to develop, we report a false negative rate estimate for tests conducted 10 or more days after symptoms. The false negative rate is often reported as "sensitivity" which is the fraction of negative test results that are true positives (i.e. were previously infected). The false negative rate (in %) is 100% -sensitivity.

Best estimate : 10-30%, corresponding to a selectivity of 70-90% 10+ days after symptom onset.

Methods of measurement and estimation : testing of samples from patients known to have SARS-CoV-2 by a combination of RT-qPCR and clinical markers (e.g. symptoms and CT scans).

Estimates :

• Testing of samples from patients with confirmed SARS-CoV-2 10+ days after onset of symptoms.

○ Table 2 of (Whitman et al. 2020) gives sensitivity as a function of days since patient-reported onset of symptoms. Note that the sample number is small in this study (< 30 for all bins). ○ (J. Zhao Jr. et al. 2020) Figure 2 and Zhao Jr. et al. 2020; ) these tests are not useful for diagnosing patients with active disease. Rather, serology testing or "serosurveys" are used to measure the incidence of the infection in the population at large in order to determine the state of the epidemic. Because these tests have non-trivial false-positive and false-negative rates, great care should be taken in interpreting the results of serosurveys.

• Since antibodies take ~10 days to develop. However, the timing of infection is often unknown.

In practice, therefore, the timing of the test will be a major factor affecting test results. • As above, error rates will depend both on which testing approach (or specific kit) is used as well as the sample collection, storage and sample handling procedures. We report a range that includes kit-to-kit variability as reported in (Whitman et al. 2020 ) but this does not include between-lab differences in sampling, transport and preparation. • The range we report (15-30% false negative rate) is the empirical range from (Whitman et al. 2020 ) and does not include statistical estimates of uncertainty. A statistical estimate of the 95% confidence interval on test sensitivity gives much wider ranges.

How does the basic reproduction number, R 0 , relate to the doubling time of the epidemic? The basic reproduction number of an infection, R 0 , is defined as the expected number of secondary infections generated by a single infected person when the population is still close to entirely susceptible (i.e. at the beginning of an epidemic, when only a small fraction of the population has been infected). R 0 describes the number of secondary infections, but gives no information about the timing of secondary infections. The characteristic time between when a primary and secondary infection is called the "generation interval". Both R 0 and the generation interval vary between individuals, but we can define average values for both of them to understand how they govern the spread of SARS-CoV-2. This basic model assumes that the pandemic starts with a single infection and the total number of infections, N(t), grows exponentially over time so that N(t) = 1 x R 0 (t/g) . Here t is the time in days and g is the generation interval, also in days, so that t/g is unitless. Given this model, the total number of cases should increase by a factor of R 0 every g days.

Let's consider an example where the number of cases doubles every 4 days. If the generation interval g is known to be ≈4 days as well, then we infer that R 0 ≈ 2 (as N(t+4)/N(t) = 2 = R 0 (4/4) = R 0 ). If instead the generation interval is known to be 8 days, then a doubling time of two days implies R 0 ≈ 4 (as N(t+4)/N(t) = 2 = R 0 (4/8)

). As such, it's important to have a high-quality estimate of the generation interval, g , when attempting to make inferences about the viral reproduction number R 0 . When there is sufficient data to estimate the distribution of generation intervals (rather than just the average value), this simple connection between R0 and the doubling time ( ) can be still be applied. See (J. Wallinga and Lipsitch 2007) for detailed discussion.

Early in the current pandemic, there was substantial uncertainty about the distribution of generation intervals and various researchers used different values to derive estimates of R 0 . As such, one should take care in comparing R 0 values between studies, making sure to evaluate the assumptions about the doubling time and generation intervals that were used to infer R 0 (see figure 2 ). The serial interval (the interval between infector and infectee symptom onset) is sometimes used as a proxy for the generation interval because it is simpler to evaluate. R 0 estimates depend on the assumed serial interval and doubling time in a complex fashion, leading to wide variation (≈2-6) in R 0 inferences. . In a few cases where the assumption regarding the serial interval wasn't explicit, we extracted it from other assumptions of the model. The background of the figure is colored by analytic estimates of the doubling times, derived from R 0 , the mean serial interval and an assumption that the serial interval is gamma distributed with a coefficient of variation of 50% (similar to explicit assumptions in some of the sources). In the few cases in which the source provides its estimate for the doubling rate, the results are similar (but not identical). Markers of studies with identical serial intervals were slightly displaced to prevent overlap. The markers are colored by the initial day in which the model assumes the exponential growth has begun (except for one source (S. ) for which the parameter couldn't be found). What causes large differences between estimates of R 0 for the same place? Although sources differ in their assumptions about the distribution of generation intervals, these differences are not the largest factor affecting the estimated R 0 . We find that a larger influence on R O arises from the presumed start date of the epidemic, denoted t 0 . Sources that assumed a start date near Dec. 1 2019 considered a much longer time period than studies assuming a start date in January 2020. Fitting over longer time periods gave slower growth rates in general, as can be seen from the following example. Let's assume that on Jan. 20th there were 1024 cases. To get to 1024 cases from 1 patient, it would take 10 doublings (2 10 = 1024). So if exponential growth began on the 31 st of December that would mean a doubling time of 20/10 = 2 days. But if the exponential growth was assumed to begin on December 1 st , that would mean that the doubling time is 50/10=5 days. This effect can be seen in figure 2 , where the color indicates the t 0 taken in each source, and in figure 3 that shows the correlation between the t 0 and the basic reproduction number, given by a regression line with R 2 =0.52, indicating a relatively high correlation. From the analysis of the difference sources, it appears that only one source directly inferred the initial data of growth from the model (Steven Sanche et al. 2020) while the others just assumed that the growth began on a specific date, even though the results are sensitive to this assumption. In conclusion, it seems that the wide variation in the exponential growth rate and reproduction number across studies of the Wuhan outbreak stems from the choice of the analysis start day.

How does the isolation of infected patients affect transmission of the virus? Quarantine and contact tracing are common means of slowing epidemics like COVID-19. These strategies involve the isolation of patients known or likely to be infected. When an individual is found to be infected (e.g. by PCR testing), they can be isolated to avoid causing secondary infections. Contact tracers can then identify people this patient has been in close contact with in recent days so that those people can isolate until their infectious period has passed. Isolation reduces the average number of secondary infections produced from a single infection, bringing it down from the basic reproduction number (R 0 the average number of people an infected person infects with no mitigation) to a lower number termed the effective reproduction number or R t . Isolation also indirectly affects disease characteristic time between when a person was infected and the time when he/she infects other people, also known as the "generation interval". To help conceptualize this effect, consider a case in which on average an infected person infects 4 people over the course of 4 days, one person one each day. This translates into an R t of 4 and an average generation interval of 2.5 days. Now let's consider the effect of quarantining infected people 2 days after their infection. These infected people can now only infect others on the first and second days, bringing their R t to 2, and shortening their generation interval to 1.5 days. This effect will tend to shorten the generation interval when compared to earlier stages of the epidemic when no countermeasures were in place (Bi et al. 2020 ) . Thus, the isolation policy affects the growth rate of the epidemic by the combination of two different effects.

When estimating the effectiveness of an intervention, it is commonly used to look at effective reproduction number (R t ), as it can be derived from the number of cases by various methods. However, most methods for estimating R t assume that the generation interval stays constant even though there is good evidence against this assumption (Cori et al. 2013; Jacco Wallinga and Teunis 2004) . Hence, these estimations of the effective reproduction number don't address the 'physical' meaning of R t : the number of infections an infectious person makes on average, but an 'operational' meaning: the reproduction number derived from the instantaneous growth rate, assuming constant generation interval. The actual average number of infections an infected person makes (the 'physical' R t ) is generally lower than the 'operational' R t . Operational R t values may be useful for predicting the trajectory of the epidemic so long as predictions are made via the same model used to infer R t . Still care should be taken in interpreting the meaning of these non-physical R t values.

What can we learn from the household secondary attack rate? The secondary attack rate is defined as the fraction of contacts who become infected. The set of people contacted by an infectious individual can be divided into various categories, for example household contacts and external contacts outside the household. Making such a distinction is useful for several reasons. First, identifying household contacts is relatively easy, which makes determining the secondary attack rate within the household much simpler than determining the overall secondary attack rate. Second, many non-pharmaceutical interventions such as mask usage, physical distancing, or lockdown affect household contacts differently from non household contacts. For example, most people do not wear masks at home. Thus, knowing the household attack rate can provide important data for predicting the efficiency of non-pharmaceutical interventions.

Let's consider a household with four individuals, one of whom is infectious. Our best estimate for the household secondary attack rate is ≈15%. This means that if we assume most infections in a household are secondary (meaning that a person was infected outside the household and now infects a totally susceptible household) the infectious household member will infect about 0.5 others on average. Assuming non-pharmaceutical interventions do not impact the behavior of people inside their homes significantly and assuming a significant fraction of new infections occur in households with no past infections, this kind of estimate can be used to produce a lower bound on the effective reproduction number (R t ). Indeed in many places where lockdown was enforced, the effective reproduction number did not decrease much below 0.5. This calculation also implies that in countries with R t close to 1, a large portion of infections occur at home (Gudbjartsson et al. 2020) . Further measures such as the isolation of infectious individuals outside their homes could potentially bring R t below this figure, as was achieved in several places in China. In addition, this calculation makes clear that R t during lockdown could be significantly influenced by the size of a representative household, which varies by a factor of ≈3 between countries (Bradbury et al. 2014) . The household reproductive number would decrease throughout the progression of the epidemic as the pool of susceptible people within a household is depleted. For example, in a household of 4 people, if one person is infected he/she can infect 3 other people. Once one of those people gets infected, they now have only 2 other potential people to infect.

What are compartmental models and what assumptions do they make? Compartmental models are one of the most prominent tools used to study the pandemic and forecast its progression. As the name suggests, these models divide the population into distinct compartments which represent different states of infection. The most commonly-used compartments are: the susceptible compartment (S), containing people who are susceptible to infection but not yet infected; the infectious compartment (I), which includes infected individuals who are contagious; and the recovered compartment (R), which includes people who were infected but are no longer infectious or susceptible, either because they are no longer shedding the virus in high quantities or because they died. These compartments describe the "SIR" model. It is common to supplement these compartments with an additional compartment called "E" for "exposed" individuals, who are not yet infectious. Models with this extra compartment are called SEIR models. An important distinction is that the infectious period (which is on the order of 4 days for half maximum infectivity) is much shorter than the overall duration of illness (on the order of a few weeks), as people's illness is usually prolonged due to the inflammatory response of the immune system. People usually stop being strongly contagious well before they recover from the disease.

In SIR and SEIR models, individuals flow through the compartments in a linear fashion -from susceptible (S), to exposed (E), to infected (I), to recovered (R). People are assumed to move between model compartments at a rate proportional to the number of individuals in the compartment. For example, people move from the infectious compartment into the recovered compartment at a constant rate, usually noted as , which is set as the inverse of the average infectious period. In the same manner, people move from the exposed compartment into the infectious compartment at a constant rate denoted , which is set as the inverse of the average latent period. Using such models, however implicitly assumes a specific type of distribution for the latent and infectious periods.

SIR and SEIR models inherently assume that the distribution of latent and infectious periods is exponential, as this is the only distribution for which the probability to transition to the next compartment is constant and independent of the time spent in the current one. An exponential distribution, however, implies that most people spend a very short time in the exposed or infectious states, which is not consistent with the inference from documented pairs of infector and infectee that people are typically contagious for ≈4-5 days (He et al. 2020) . Thus, some extended models employ a "trick" to make the distributions more realistic. This trick involves splitting up the exposed and infectious compartments into N sub-compartments each, and multiplying the rate at which people move between those sub-compartments by the N. This way, the sum of people in the exposed sub-compartment represents all the exposed people, and the same holds true for the infectious compartment. Now, however, the time spent in the exposed or infectious compartments will be distributed as a sum of N exponentials, which is called the Erlang distribution. This distribution is similar in shape to the distributions observed when studying infector-infectee pairs.

What is the effect of double testing patients by RT-qPCR? PCR testing of patient samples is the primary mode of diagnosing patients presenting COVID-19 symptoms. In the sections dedicated to the accuracy of PCR testing we gave references supporting an RT-qPCR false negative rate of ≈20% and a false positive rate ≈1%. In general, false negatives are far more concerning than false positives because they are much more likely and also because the consequences are far more serious: a false negative results in improper treatment of an infected individual and, if abundant, false negatives are likely to result in increased transmission. Several sources recommend multiple testing of patient samples to reduce the number of false negatives.

Let's consider a patient who is, in fact, infected with SARS-CoV-2. If repeated RT-qPCR tests are statistically independent and conducted at roughly the same time (relative to the onset of symptoms) then they should each have the same false negative rate of ≈20%. The odds of getting two negative tests given a positive patient should then be 0.2 2 = 4%. In contrast, (Jiang et al. 2020 ) report a 22% false negative rate for a single test and 14% for two tests. If tests were independent, the two-test rate should have been reduced to ≈5% (a 17 percentage points reduction) but double-testing gave an empirical false negative rate of ≈14% (an 8 percentage points reduction). So double-testing had roughly half the expected effect in this instance. This calculation implies that PCR tests are not fully independent. One reason that this might be the case is that the second test is always conducted after the first (by definition) and patient viral loads change over time, typically decreasing below the limit of detection ≈10 days after symptoms (see "Duration of PCR positivity").

Let's consider two subsequent RT-qPCR tests. If we assume that the first test was conducted when the patient had near-maximal viral load (3-4 days after symptom onset, ≈20% false negatives) and the second test was conducted two days later, it might have a substantially greater false negative rate approaching 40-50% as reported in Figure 2 of (J. Zhao Jr. et al. 2020) . If the first test has a false negative rate of 22% and the second ≈50%, then the two-test rate should be about 14%, similar to the 14% rate observed. A recent modeling effort by (Wikramaratna et al. 2020 ) performed a similar, albeit more sophisticated calculation of the effect of multiple testing assuming a 1 day delay between subsequent tests, arriving at false negative rates similar to those empirically observed for two-sample RT-qPCR. As PCR-positivity is observed to decrease over time, their calculation recommends rapid testing early in the disease progression (i.e. quickly after symptoms present) to minimize the false negative rate of both single and double tests.

Another line of explanation is that various systematic biases cause the tendency for false negative results (say the physiological state of the patient) and such systematic reasons are correlated across repeated tests.

• What is the effect of climate on the transmission of COVID-19?

• What is the quantitative effect of non-pharmaceutical interventions on the spread of the virus? • What is the quantitative risk of infection with SARS-CoV-2 through surfaces? • What is the infectious dose of SARS-CoV-2?

• What is the quantitative risk of reinfection from SARS-CoV-2? References (From vignettes, definitions and caveates. Measurements & estimates have direct links to papers)

Analytical Sensibility and Specificity of Two RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow

Epidemiology and Transmission of COVID-19 in 391 Cases and 1286 of Their Close Contacts in Shenzhen, China: A Retrospective Cohort Study

A New Framework and Software to Estimate Time-Varying Reproduction Numbers during Epidemics

Quantifying SARS-CoV-2 Transmission Suggests Epidemic Control with Digital Contact Tracing

Report 3: Transmissibility of 2019-nCoV

Application and Optimization of RT-PCR in Diagnosis of SARS-CoV-2 Infection

Viral Dynamics in Mild and Severe Cases of COVID-19

Superspreading and the Effect of Individual Variation on Disease Emergence

Using Observational Data to Quantify Bias of Traveller-Derived COVID-19 Prevalence Estimates in Wuhan, China

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Estimating the Burden of SARS-CoV-2 in France

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

Improved Inference of Time-Varying Reproduction Numbers during Infectious Disease Outbreaks

Temporal Profiles of Viral Load in Posterior Oropharyngeal Saliva Samples and Serum Antibody Responses during Infection by SARS-CoV-2: An Observational Cohort Study

Analytical Sensitivity and Efficiency Comparisons of SARS-COV-2 qRT-PCR Assays

Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures

How Generation Intervals Shape the Relationship between Growth Rates and Reproductive Numbers

Estimating False-Negative Detection Rate of SARS-CoV-2 by RT-PCR

Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019

Preliminary Estimation of the Basic Reproduction Number of Novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A Data-Driven Analysis in the Early Phase of the Outbreak

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients